A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer.

Linking the molecular aberrations of cancer to drug responses could guide treatment choice and identify new therapeutic applications. However, there has been no systematic approach for analyzing gene-drug interactions in human cells. Here we establish a multiplexed assay to study the cellular fitnes...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Muellner, M, Uras, I, Gapp, B, Kerzendorfer, C, Smida, M, Lechtermann, H, Craig-Mueller, N, Colinge, J, Duernberger, G, Nijman, S
Format: Journal article
Język:English
Wydane: 2011